Sort
8,912 grants matching “sars cov 2”
The Role of COVID-19 Endothelial Cell Dysfunction and Hypercoagulability in the Development of Post-ICU Cognitive Impairment and Dementia
$237,750Sophia Wang · Indiana University Indianapolis · R21 · FY2022 · AG
Pediatric COVID-19 Dashboard and Clinical Phenotypes
$237,623Tellen Bennett · University Of Colorado Denver · R01 · FY2023 · HD
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease
$237,514Robyn Therese Domsic · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AR
Analysis Resource Core
$237,501Scott L. Zeger · Johns Hopkins University · U54 · FY2022 · CA
Targeting the Ghrelin System for Novel Opioid Use Disorder Therapeutics
$237,381Kathryn A. Cunningham · University Of Texas Med Br Galveston · UG3 · FY2020 · DA
A Helminth-Derived Immune Potentiator for Biodefense
$237,000New York Blood Center · R21 · FY2005 · AI
mRNA COVID-19 Vaccines Delivered with Plant Virus/Polymer Devices
$237,000Nicole Franziska Steinmetz · University Of California, San Diego · R21 · FY2021 · AI
Mechanistic & Crystallographic Studies of SARS Proteases
$236,986Andrew D Mesecar · University Of Illinois At Chicago · P01 · FY2006 · AI
Impact of Alcohol Misuse on Cognitive and Respiratory Outcomes in COVID-19-associated Acute Respiratory Failure
$236,921Ellen L Burnham · University Of Colorado Denver · R01 · FY2023 · AA
Seeing the Unseen: High-Throughput Prospective Profiling and inhibition of SARS-CoV-2 receptor-binding domain variants
$236,919Sagar D Khare · Rutgers, The State Univ Of N.J. · R21 · FY2023 · AI
Discovery of Novel Anti-inflammatory, Non-immunosuppressive Molecules forMitigation of Cytokine Storm in COVID-19 Patients
$236,387Mehran F Moghaddam · Orox Biosciences, Inc. · R43 · FY2022 · HL
Intracellular functions and mechanisms of alphavirus ion channel 6K
$236,286Joyce Jose · Pennsylvania State University, The · R21 · FY2023 · AI
Impact of SARS-Cov-2 on a Rat Model Cerebral Amyloid Angiopathy
$236,250William E. Van Nostrand · University Of Rhode Island · R21 · FY2025 · AG
E-PROOF: E-intervention for Protein Intake and Resistance Training to Optimize Function
$236,250Jessica L. Krok-Schoen · Ohio State University · R21 · FY2023 · AG
Therapy for long-COVID in a preclinical model
$236,250Daniel Kaufman · University Of California Los Angeles · R21 · FY2024 · AI
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
$236,250Deborah J Lenschow · Washington University · R21 · FY2022 · AI
Obesity and COVID-19: Role of Adipose Tissue
$236,175Tracey McLaughlin · Stanford University · R21 · FY2021 · AI
Characterization of host immune responses to SARS-CoV-2
$236,110Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Covalent inhibitors of host cell entry by SARS-CoV-2 for treatment of COVID-19
$236,100Matthew S Bogyo · Stanford University · R21 · FY2023 · AI
Determining SARS-CoV host gene requirements by mutagenesis and RNA interface
$236,097Robert J Hogan · University Of Georgia · R21 · FY2007 · AI
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
$235,887Jun Wang · State University New York Stony Brook · R21 · FY2022 · AI
Qungasvik (Toolbox): Prevention of Alcohol/Suicide Risk in Alaska Native Youth
$235,846Stacy M. Rasmus · University Of Alaska Fairbanks · R01 · FY2020 · AA
A decision tool to inform the optimal use of non-pharmaceutical interventions during the COVID-19 pandemic
$235,692Reza Yaesoubi · Yale University · R21 · FY2024 · AI
Live-cell imaging of SARS-CoV-2 replication organelle formation and RNA synthesis
$235,550Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · AI
ACE2-independent alternative receptors for SARS-CoV-2 at the oral mucosa
$235,500Theresa L Chang · Rutgers Biomedical And Health Sciences · R21 · FY2024 · DE